Advanced search
Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 43, 2019 - Issue 3
Submit an article Journal homepage
372
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Barriers to the use of hydroxyurea in the management of sickle cell disease in Nigeria

Titilope A. AdeyemoDepartment of Haematology and Blood Transfusion, College of Medicine, University of Lagos, Lagos, Nigeria; ;Department of Haematology and Blood Transfusion, Lagos University Teaching Hospital, Id-Aarba, Lagos, Nigeria; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-2097-469X
ORCID Icon,
Ijeoma N. Diaku-AkinwunmiDepartment of Paediatrics, Lagos State College of Medicine, Ikeja, Lagos, Nigeria;
,
Oyesola O. OjewunmiDNA Laboratory, Sickle Cell Foundation Nigeria, Lagos, Nigeria;
,
Abiola B. BolarinwaDepartment of Haematology and Blood Transfusion, Lagos University Teaching Hospital, Id-Aarba, Lagos, Nigeria;
&
Adekunle D. AdekileDepartment of Paediatrics, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait
Pages 188-192 | Received 23 May 2019, Accepted 06 Jul 2019, Published online: 29 Aug 2019

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Emmanuela E Ambrose, Benson R Kidenya, Mwesige Charles, Joyce Ndunguru, Agnes Jonathan, Julie Makani, Irene K Minja, Paschal Ruggajo & Emmanuel Balandya. (2023) Outcomes of Hydroxyurea Accessed via Various Means and Barriers Affecting Its Usage Among Children with Sickle Cell Anaemia in North-Western Tanzania. Journal of Blood Medicine 14, pages 37-47.
Read now

Articles from other publishers (16)

Laura Drown, Miriam Osei, Ada Thapa, Chantelle Boudreaux, Natasha Archer, Gene Bukhman & Alma J Adler. (2024) Models of care for sickle cell disease in low-income and lower-middle-income countries: a scoping review. The Lancet Haematology 11:4, pages e299-e308.
Crossref
Alex Pizzo, Jerlym S. Porter, Yvonne Carroll, Adam Burcheri, Matthew P. Smeltzer, Molly Beestrum, Chinonyelum Nwosu, Sherif M. Badawy, Jane S. Hankins, Lisa M. Klesges & Nicole M. Alberts. (2023) Provider prescription of hydroxyurea in youth and adults with sickle cell disease: A review of prescription barriers and facilitators. British Journal of Haematology 203:5, pages 712-721.
Crossref
Lucio Luzzatto. (2023) Sickle cell disease strategies and priorities. The Lancet Haematology 10:10, pages e794-e795.
Crossref
Mwashungi Ally & Emmanuel Balandya. (2023) Current challenges and new approaches to implementing optimal management of sickle cell disease in sub-Saharan Africa. Seminars in Hematology 60:4, pages 192-199.
Crossref
Abwalaba R.Okoth J.Esamai F.. (2023) Exploring the Association of Sociodemographic Factors with Musculoskeletal Pain among Children with Sickle Cell Disease. African Journal of Health, Nursing and Midwifery 6:3, pages 35-45.
Crossref
Omer Koras, Sadık Gorur, Hanifi Bayramogulları, Gul Ilhan, Fatih Gokalp, Murat Kacmaz, Alican Ilgezdi, Ekrem Yıldırak, Hakan Sigva, Nezih Tamkac & Sefa Burak Porgalı. (2022) Elastographic evaluation of the effect of sickle cell anemia on testicles: a prospective study. Andrologia 54:8.
Crossref
Shahida Khan, Ghazi Damanhouri, Tahir Jameel Ahmed, Saeed Halawani, Ashraf Ali, Ahmad Makki & Sarah Khan. (2022) Impact of omega-3 fatty acids supplementation in children with sickle cell disease in Saudi Arabia. Journal of King Saud University - Science 34:4, pages 101942.
Crossref
Reuben Ikechukwu Chianumba, Akinyemi O. D. Ofakunrin, Jack Morrice, Olaniyi Olanrewaju, Oluseyi Oniyangi, Aisha Kuliya-Gwarzo, Uche Nnebe-Agumadu, Hezekiah Alkali Isa & Obiageli Eunice Nnodu. (2022) Outcome of Hydroxyurea Use in SCD and Evaluation of Patients’ Perception and Experience in Nigeria. Frontiers in Genetics 13.
Crossref
Emmanuel Chide Okocha, Joyce Gyamfi, Nessa Ryan, Oluwatoyin Babalola, Eno-Abasi Etuk, Reuben Chianumba, Maxwell Nwegbu, Hezekiah Isa, Anazoeze Jude Madu, Samuel Adegoke, Uche Nnebe-Agumandu, Biobele Brown, Emmanuel Peprah & Obiageli E. Nnodu. (2022) Barriers to Therapeutic Use of Hydroxyurea for Sickle Cell Disease in Nigeria: A Cross-Sectional Survey. Frontiers in Genetics 12.
Crossref
Lucio Luzzatto & Julie Makani. (2022) Treating Rare Diseases in Africa: The Drugs Exist but the Need Is Unmet. Frontiers in Pharmacology 12.
Crossref
Shimaa Ramadan, Amany Mohamed Hegab, Yahya S. Al-Awthan, Mohammed Ali Al-Duais, Ahmed A. Tayel & Mahmoud A. Al-Saman. (2021) Comparison of the Efficiency of Lepidium sativum, Ficus carica, and Punica granatum Methanolic Extracts in Relieving Hyperglycemia and Hyperlipidemia of Streptozotocin-Induced Diabetic Rats. Journal of Diabetes Research 2021, pages 1-12.
Crossref
Benoît Mukinayi Mbiya, Didier Kalenda Kalombo, Yannick Nkesu Mukendi, Valery Daubie, John Kalenda Mpoyi, Parola Mukendi Biboyi, Ghislain Tumba Disashi & Béatrice Gulbis. (2021) Improvement of SCD morbimortality in children: experience in a remote area of an African country. BMC Health Services Research 21:1.
Crossref
Uche Nnebe‐Agumadu, Innocent Adebayo, Ifeanyi Erigbuem, Esther James, Evelyn Kumode, Obiageli Nnodu & Adekunle Adekile. (2021) Hydroxyurea in children with sickle cell disease in a resource‐poor setting: Monitoring and effects of therapy. A practical perspective. Pediatric Blood & Cancer 68:6.
Crossref
Emmanuel Olawale Olamijuwon. (2021) Characterizing low effort responding among young African adults recruited via Facebook advertising. PLOS ONE 16:5, pages e0250303.
Crossref
Joyce Gyamfi, Temitope Ojo, Sabrina Epou, Amy Diawara, Lotanna Dike, Deborah Adenikinju, Scholastica Enechukwu, Dorice Vieira, Obiageli Nnodu, Gbenga Ogedegbe & Emmanuel Peprah. (2021) Evidence-based interventions implemented in low-and middle-income countries for sickle cell disease management: A systematic review of randomized controlled trials. PLOS ONE 16:2, pages e0246700.
Crossref
Alexandra Power-Hays & Russell E. Ware. (2020) Effective use of hydroxyurea for sickle cell anemia in low-resource countries. Current Opinion in Hematology 27:3, pages 172-180.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.